PubMed Health⌕ Search

Biomedical subjects

S Mimoun

Publications and source records attributed to S Mimoun.

11 recordsLinked to original sources
PubMed2004

[High frequency ultrasonography and celluscore: an improvement in the objective evaluation of cellulite phenomenon].

As they usually do not have any serious effect on health condition, cellulite phenomenons are not considered as potentially hazardous by general practitioners; unfortunately they involve almost all the feminine population after the forties and may really induce bad side effects either psychological or physical whatever the confusing origin of that cutaneous deformation: heredity, nutrition, circulatory and hormonal diseases etc. Trying to appreciate in a more scientific way this superficial skin disorder, we have developed a computerised questionnaire which can be combined with the finest upto date way of skin exploration, high frequency ultrasonography. It seems possible to consider now cellulite as the result of various disorders which can be separate into fibrotic or retentional phenomenons (surrounding superficial fat tissues) and the direct adipocyte reaction (adiposis). We hope to be able in the future to extend the treatment of cellulite beyond the limits of liposuction which seems until today the only way to bring some improvement to that phenomenon in spite of the very delicacy of the surgical approach.

Adipose Tissue↗
PubMed2003

[Menopause, andropause and sexual function].

After about fifty years of age, at the time of the menopause and the andropause (androgenic deficiency), men as well as women can have the same type of complaint, but it is facing time that women have a different view from men. Time is coded into a woman's body, whereas it is by 'social' time that men are more often determined. On the sexual level there is a slow-down in the sexual reactions of both men and women. One should not forget, however, that the cure for sexual problems in women sometimes involves the treatment of male sexual dysfunction (erection problems, premature ejaculation, absence of ejaculation). Therapeutically, hormonal replacement therapy is undoubtedly a help, if there are no medical contra-indications and if the patient is in agreement. If the complaint is also sexual then a more specific, therapeutic treatment may often be necessary, associating hormone treatment with erection inducers.

Aging↗
PubMed2000

[The experience of menstruation and its disorders in 603 women using contraception in 1999].

AIM: An epidemiological survey completed during the first quarter of 1999 assesses the frequency of menstrual disorders as well as their effects on the lives of women using contraception. MATERIALS AND METHODS: The results presented involve a sample of 603 women, with 405 using the pill and 198 fitted with an IUD. The average age of onset of menstruation in the sampled population was 12.8 years. Although most women declared that they felt no anxiety at the time, over one-third of the women surveyed explained that they felt a certain hesitancy in discussing the topic. Even today, certain feelings, such as shame or pride, are still evoked in the interviews. Although over half believe that it is normal to menstruate, the process is nevertheless considered "somewhat bothersome" by certain women who also refer to "purification." Traditional cultural perspectives remain a strong influence. Menstrual disorders predating the initial use of contraception were reported in 150 women (occasional intermenstrual bleeding, 130 cases; other anomalies excluding metrorrhagia, 27 cases). Even if most of the women believe these problems to be inevitable, they also claim to be relatively troubled by these disorders, which often involve a considerable degree of discomfort. Such disorders are significantly more frequent in the "IUD" group, as well as in women who claim a very early onset of menstruation and those who consider explanations provided by the physician as "insufficient." CONCLUSION: The difference creates a certain fear with respect to any social or individual norm that may have been internalized. Thus the information presented in this study may provide ways and means to better understand women in general and our women patients in particular.

Adolescent↗
PubMed1996

[Menopause and sexuality].

Many researchers have noted a direct correlation between sexual difficulties and E2 level, when E2 < 50 pg/ml. But sexual behavior also interferes with sexuality. In Bachmann and coll. study, sexually active women ranging from 60 to 70, without HRT had higher mean levels of E2 and T than sexually inactive women. Of course the numerous complaints of that period (hot flushes, asthenia, tachycardia...) are creating physical and psychological conditions rather damaging for sexuality. They may also induce a state of true suffering with a loss of self esteem resulting in a more introverted way of life. In other cases, it is the psychological context in it self (depression, anxiety, relational difficulty with the partner or even male sexual problems) which is interfering. An actual amelioration of sexual life can be obtained with HRT plus or a minima percutaneous androgenotherapy in some cases. The treatment is indeed an asset for the therapeutic support, even from the psychotherapeutic point of view.

Estrogen Replacement Therapy↗
PubMed1994

[Sexual disorders after radical prostatectomy and their treatment. Psychological aspects].

Forty-one men who had undergone radical prostatectomy and their wives were interviewed in order to evaluate the erectile disorders encountered after this operation and to facilitate therapeutic impact. Twenty-three of the women stated they were satisfied with their sexual intercourse before the operation and among them, 16 (70%) stated they were unsatisfied after their husband's operation. Among these 16 couples, 10 accepted sexual counselling which led to satisfaction with sexual intercourse in 8 couples. Sexual counselling was the only therapy needed in 1 couple, 4 men received intracavernous injections and 3 used a vacuum system. These results, as well as the impact of integrating the sexual partner in the treatment protocol for erectile impairment were discussed.

Aged↗
PubMed1994

[Prostaglandin E1 in the treatment of erectile insufficiency. Comparison of efficacy and tolerance based on different etiologies].

Prostaglandin E1 (PGE1) is widely used for the treatment of impotence. We retrospectively studied 322 patients who had received injection of prostaglandin E1 from 1991 to 1993 and attempted to divide them into different subgroups as a function of the aetiology of the impotence in order to determine whether there is a difference in efficacy and tolerance. The complete work up included at least two consultations with a sex therapist, a pharmaco-Doppler examination, cavernometry, plethysmography of the nocturnal erections and blood chemistry with assay of the free testosterone in all patients. Erections compatible with penetration were observed after prostaglandin E1 injection in 85.4% of the patients (all aetiologies). Very favourable results were obtained in the group of patients with an arterial defect (n =36) since erections allowing intercourse were obtained in 83.3%. For the patients with occlusive venous dysfunction (cavernous leakage) (n = 35) the injections were less effective but led to satisfactory results in 74.3%. The results were excellent (94.7%) in the cases of psychogenic impotence (n = 113). Finally, in patients with diabetes related impotence (n = 21), the treatment was much less effective giving only 52.3% of positive results. In several cases (n = 151) we were able to compare the effectiveness of PGE1 with that of papaverine alpha blockers. For the patients with an arterial defect, PGE1 was slightly more effective. For patients with an occlusive venous dysfunction, PGE1 was always more effective than papaverine and finally, for patients with diabetes, the papaverine-alpha blocker combination was more effective than PGE1 in all cases.(ABSTRACT TRUNCATED AT 250 WORDS)

Adrenergic alpha-Antagonists↗
PubMed1993

[The multiple interactions between infertility and sexuality].

After investigating into literature and clinical experience, we shall line out in this study 4 types of interactions between sexuality and infertility: sexual causes to feminine (vaginism, with and without heavy dyspareunia) or masculine (impotency, ante-portas ejaculation, anejaculation, dysejaculation), infertility; influence of tests and of treatments for infertility on sexual life; influence of infertility on sexuality focusing on the various ambiguous feelings (of culpability, inferiority, aggressivity, passivity); and last, the psychological and sexual interactions with medical assisted procreation, reinforcing the sexual separation of man and woman if the body is considered a machine. Psychosomatic guidance of the couple during these steps (with reassurance as the being helped conception) will allow maintaining on removing sexual attraction.

Attitude to Health↗
PubMed1992

[Chronic prostatodynia and psychosomatic care].

Depression is a regular accompaniment of all chronic painful conditions. A study was conducted to assess the effect of treatment of the depressive factor in patients with chronic prostatodynia. Effects were compared of psychosomatic therapy (psychotherapy, relaxation, etc.) alone in 9 patients (group I) and the same psychosomatic care plus treatment with amineptine and clobazam in 9 patients (group II). Results showed that 2 patients recovered and 3 were improved (62%) with 1 drop-out in group II, versus recovery and 2 improvements (42%) with 2 drop outs in group I. These findings are analyzed and discussed.

Adult↗